MedPath

LiPO Teen (the Lifestyle in Pregnancy and Offspring Teenagers

Not Applicable
Recruiting
Conditions
Obesity
Gestational Weight Gain
Follow-up
Life Style, Healthy
Body Weight
Interventions
Behavioral: Lifestyle intervention Dietary advise and/or advise on physical activity
Registration Number
NCT05774652
Lead Sponsor
Odense University Hospital
Brief Summary

The study is a follow-up of a Randomized Controlled Trial (RCT) performed in 2007-10 - the "Lifestyle in Pregnancy" LiP study.

The LiP study included 360 pregnant women with BMI ≥30 kg/m2 from Odense University Hospital and Aarhus University Hospital. The women were randomized to intervention with low-calorie diet and physical activity from gestational age 10-14 in pregnancy and until delivery - or to a standard care control group. The objective of the LiPO-Teen project is to perform a clinical follow-up study of the eligible 301 mothers who completed the trial until delivery with a liveborn child, and their 14 year-old offspring. The overall ambition is to understand whether lifestyle intervention in pregnancy prevents obesity and its complications across generations, with a specific focus on modifiable factors.

Detailed Description

LiPO Teen (the Lifestyle in Pregnancy and Offspring Teenagers): Identification of modifiable risk factors for childhood obesity - a follow-up of a randomized controlled trial.

The objective of the LiPO-Teen project is to perform a clinical follow-up study of the eligible 301 mothers who completed the trial until delivery with a liveborn child, and their 14 year-old offspring.

In the original trial women were randomized 1:1 to intervention or control. The participants (both mother and child in pair) who completed the initial LiP study will be invited to a 2-hour examination now 14 years after the intervention during pregnancy to evaluate the effect of the intervention on both mother and child long term.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
301
Inclusion Criteria
  • Mothers in the initial LiP study selected at the baseline study in 2007-2010
  • Teenagers of mothers in the initial LiP study
Read More
Exclusion Criteria

• None

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Diet + physical activityLifestyle intervention Dietary advise and/or advise on physical activityDiet + physical activity Dietary advise and advise on physical activity
Primary Outcome Measures
NameTimeMethod
Fat mass index , measured by DEXA scan.2 years data collection

Body composition Assessed by Dual-Energy X-ray Absorptiometry (DEXA). Hologic Horizon, serie number: 301872M. Fat mass, lean mass and bone density will be calculated.

Fat mass index in both mothers and offspring (Fat mass index (FMI) defined as: FM (kg) / height (m)2).

Secondary Outcome Measures
NameTimeMethod
Vitamin D2 years data collection

Blood sample: Vitamin D

Electrolytes2 years data collection

Blood sample: Electrolytes

Insulin2 years data collection

Blood sample: Insulin

C-peptide2 years data collection

Blood sample: C-peptid

Adiponectin2 years data collection

Blood sample: Adiponectin.

Leukocytes2 years data collection

Blood sample: Leukocytes

Kidney function (e-GFR)2 years data collection

Blood sample: Kidney function (e-GFR)

Blood pressure2 years data collection

Standardized sitting measurement, average of 3 measures. Both systolic and diastolic blood pressure will be measured.

Metabolic markers2 years data collection

Blood samples: Lipids (total cholesterol, HDL, LDL, triglyceride)

Diet composition2 years data collection

Assessed by FFQ (food frequency questionnaire), validated to mother and child respectively

Physical activity (PA)2 years data collection

Pattern and level of PA will be measured 7 days (24/7) monitored by activity tracker on the wrist (Actigraph GT3X+).

Epigenetic examinations2 years data collection

Blood samples:

The epigenetic profile of DNA samples extracted from whole blood will be characterized by Genome-wide DNA methylation using Infinium MethylationEPIC v2.0 Kit. Principle component and hierarchical clustering analyses will be used to identify associations between methylation patterns and a range of clinical characteristics, biomarkers as well as gene expression levels (RNAseq).

Metabolic and inflammatory markers2 years data collection

Blood samples: Glucose

Glycemic variability2 years data collection

Continuous glucose monitoring (CGM, DEXCOM G6Pro): 10 days recording of fasting glucose and postprandial glucose values. Glucose variability will be assessed using a device, which performs repeated glucose measurements in the skin providing insights into glucose fluctuations throughout the day and night.

Mental health2 years data collection

Assessed by questionnaires, validated to mother and child respectively

Puberty stage2 years data collection

According to the classifications of Marshall and Tanner

Leptin2 years data collection

Blood sample: Leptin

HsCRP.2 years data collection

Blood sample: HsCRP.

IL62 years data collection

Blood sample: IL6

Selenium2 years data collection

Blood sample: Selenium

Zinc.2 years data collection

Blood sample: Zinc

Ferritin2 years data collection

Blood sample: Ferritin

Liver enzymes2 years data collection

Blood sample: Liver enzymes

HbA1c2 years data collection

Blood samples: HbA1c

Trial Locations

Locations (1)

Steno Diabetes Center Odense

🇩🇰

Odense, Denmark

© Copyright 2025. All Rights Reserved by MedPath